Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internal Medicine | 1 | 2009 | 27 | 0.330 |
Why?
|
| Educational Measurement | 1 | 2009 | 111 | 0.320 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 207 | 0.280 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 279 | 0.270 |
Why?
|
| Internship and Residency | 1 | 2009 | 224 | 0.270 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 918 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2010 | 322 | 0.190 |
Why?
|
| Clusterin | 1 | 2010 | 5 | 0.090 |
Why?
|
| Lipoproteins, HDL | 1 | 2010 | 41 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2010 | 31 | 0.090 |
Why?
|
| Medical Staff, Hospital | 1 | 2009 | 21 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2010 | 77 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2010 | 165 | 0.080 |
Why?
|
| Cardiac Myosins | 1 | 2008 | 12 | 0.080 |
Why?
|
| Myocarditis | 1 | 2008 | 16 | 0.080 |
Why?
|
| Nerve Growth Factors | 1 | 2008 | 24 | 0.080 |
Why?
|
| Serpins | 1 | 2008 | 31 | 0.080 |
Why?
|
| Students, Medical | 1 | 2009 | 95 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2009 | 204 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 32 | 0.080 |
Why?
|
| Curriculum | 1 | 2009 | 262 | 0.070 |
Why?
|
| Platelet Count | 1 | 2008 | 112 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2008 | 197 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 121 | 0.070 |
Why?
|
| Blood Platelets | 1 | 2008 | 203 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2008 | 466 | 0.060 |
Why?
|
| Obesity | 1 | 2010 | 650 | 0.060 |
Why?
|
| Humans | 5 | 2010 | 26829 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2010 | 386 | 0.040 |
Why?
|
| Middle Aged | 3 | 2010 | 6818 | 0.030 |
Why?
|
| Adult | 3 | 2010 | 7383 | 0.030 |
Why?
|
| Indicator Dilution Techniques | 1 | 2010 | 7 | 0.020 |
Why?
|
| Washington | 1 | 2010 | 12 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 73 | 0.020 |
Why?
|
| Triglycerides | 1 | 2010 | 117 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 197 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 113 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 177 | 0.020 |
Why?
|
| Adrenergic beta-2 Receptor Antagonists | 1 | 2008 | 4 | 0.020 |
Why?
|
| Propranolol | 1 | 2008 | 38 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2008 | 14 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2008 | 65 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 700 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 33 | 0.020 |
Why?
|
| Creatinine | 1 | 2008 | 57 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2008 | 23 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2008 | 64 | 0.020 |
Why?
|
| Glycated Hemoglobin A | 1 | 2008 | 64 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 93 | 0.020 |
Why?
|
| Thrombin | 1 | 2008 | 68 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 747 | 0.020 |
Why?
|
| Epitopes | 1 | 2008 | 171 | 0.020 |
Why?
|
| Collagen | 1 | 2008 | 147 | 0.020 |
Why?
|
| Lipids | 1 | 2008 | 195 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 733 | 0.020 |
Why?
|
| Oklahoma | 1 | 2010 | 973 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 674 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 266 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1036 | 0.020 |
Why?
|
| Male | 2 | 2010 | 12870 | 0.010 |
Why?
|
| Adolescent | 1 | 2008 | 2957 | 0.010 |
Why?
|
| Female | 1 | 2008 | 14463 | 0.010 |
Why?
|